recent articles
Alpenglow Biosciences and Virdx: Multi-year, milestone-based collaboration to accelerate the development of tools that bridge radiology and pathology. Aims to improve prostate cancer diagnosis and reduce unnecessary interventions. ...
SEATTLE--(BUSINESS WIRE)--Alpenglow Biosciences, a leading 3D spatial biology company, was recently awarded contracts from Advanced Research Projects Agency for Health (ARPA-H) and the National Institutes of Health (NIH) and secured additional...
Alpenglow is an inaugural recipient of Andy Hill grant, Washington's Cancer Research Endowment (CARE) fund to create AI-enabled 3D spatial biology of cancer biopsies Aims of the grant include developing a 3D database of prostate...
Alpenglow Biosciences and CorePlus partner together to bring 3D Spatial Biology to clinical research and development SEATTLE and CAROLINA, Puerto Rico, July 19, 2022 /PRNewswire/ -- Alpenglow Biosciences (Alpenglow), developers of an...